Abstract:Background: Cognitive impairment influenced by brain dysconnectivity and inflammatory cytokines has consistently been the most prominent feature across major psychiatric disorders (MPDs) including schizophrenia, bipolar disorder, and major depressive disorder. The commonalities call upon a trans-diagnostic and dimensional approach in delineating the neural mechanisms underlying the relationship between brain connectivity, cognition, and inflammation among MPDs.Methods: 1543 participants, including 1058 with MPDs and 485 healthy controls, from a single site were enrolled in this study. Participants underwent diffusion tensor imaging and resting-state functional magnetic resonance imaging, with the majority of participants (n = 1169, 765 participants with MPDs and 404 healthy controls) also completing the Wisconsin Card Sorting Test (WCST). Blood samples were obtained from 325 participants within 24 h of imaging. Fractional anisotropy (FA) and regional functional connectivity (FC) were used to measure structural and functional connectivity, respectively.Findings: Differences in inflammatory cytokine indices were assessed using IL-1β, IL-6 and TNF-α. WCST deficits were associated with decreased FA; increased regional FC; and elevated IL-1β, IL-6 and TNF-α among MPDs. Overlapping structural and functional dysconnectivity within the frontolimbic-striatal regions contributed to cognitive deficits among MPDs. Mediation analyses revealed that IL-1β mediated the association between FA and WCST and that IL-6 mediated the relationship between regional FC and WCST.Interpretation: Our findings implicate an intriguing mechanism for the effects of inflammation on cognitive function through different molecular-brain-cognition pathways among MPDs. Specific cytokine influences allow for more targeted studies and potentially more targeted interventions that may improve cognition in MPDs.Funding Statement: This study was funded by National Science Fund for Distinguished Young Scholars (81725005 to F.W.), National Natural Science Foundation of China (81571311 to Y.T., 81571331 to F.W.), National Key Research and Development Program (2018YFC1311604 to Y.T., 2016YFC1306900 to Y.T., 2016YFC0904300 to F.W.), National High Tech Development Plan (863) (2015AA020513 to F.W.), Liaoning Science and Technology Project (2015225018 to Y.T.), Liaoning Education Foundation (Pandeng Scholar to F.W.), Innovation Team Support Plan of Higher Education of Liaoning Provience (LT2017007 to F.W.), and Major Special Construction plan of China Medical University (3110117059 to F.W.).Declaration of Interests: The authors report no biomedical financial interests or potential conflicts of interest.Ethics Approval Statement: The study was approved by the Institutional Review Board of China Medical University and was performed in accordance with the Declaration of Helsinki. All experiments and methods were performed in accordance with approved guidelines and regulations. All subjects provided written informed consent.

Inflammatory cytokines, cognition, and response to antidepressant treatment in patients with major depressive disorder

Linking peripheral IL-6, IL-1 and hypocretin-1 with cognitive impairment from major depression

Peripheral Cytokine Levels and Response to Antidepressant Treatment in Depression: a Systematic Review and Meta-Analysis

The relationship between plasma cytokine levels and antidepressant response in patients with first-episode major depressive disorder

Fluoxetine Treatment for Major Depression Decreases the Plasma Levels of Cytokines

Sex differences in the association of plasma cytokines and neurocognition in first-episode major depressive disorder

Association Between Increased Serum Interleukin-8 Levels and Improved Cognition in Major Depressive Patients with SSRIs

Different levels of pro- and anti-inflammatory cytokines in patients with unipolar and bipolar depression.

The effect of inflammation markers on cortical thinning in major depressive disorder: A possible mediator of depression and cortical changes

Association between inflammatory cytokines and symptoms of major depressive disorder in adults

Gut Microbiome Composition Linked to Inflammatory Factors and Cognitive Functions in First-Episode, Drug-Naive Major Depressive Disorder Patients

Changes in Insulin Resistance Following Antidepressant Treatment Mediate Response in Major Depressive Disorder.

Changes in the Serum Levels of Inflammatory Cytokines in Antidepressant Drug-Naïve Patients with Major Depression

Sex Difference in IL-6 Modulation of Cognition among Chinese Individuals with Major Depressive Disorder

Low-Grade Inflammation as a Predictor of Antidepressant and Anti-Inflammatory Therapy Response in MDD Patients: A Systematic Review of the Literature in Combination With an Analysis of Experimental Data Collected in the EU-MOODINFLAME Consortium

Resting-state functional connectivity is correlated with peripheral inflammatory markers in patients with major depressive disorder and healthy controls

Inflammatory Cytokines Mediate Brain Dysconnectivity and Cognitive Deficits Across Major Psychiatric Disorders

Elevated Systemic Inflammation Is Associated with Reduced Corticolimbic White Matter Integrity in Depression

Connectivity of the Cognitive Control Network During Response Inhibition as a Predictive and Response Biomarker in Major Depression: Evidence From a Randomized Clinical Trial

Inflammation-related abnormal dynamic brain activity correlates with cognitive impairment in first-episode, drug-naïve major depressive disorder

The association between overweight/obesity and poor cognitive function is mediated by inflammation in patients with major depressive disorder